Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
6th grade Avg
|
New words:
adjunctive, antipsychotic, autistic, behavior, biosimilar, bipolar, Casey, connection, credit, Division, Donald, Eisai, epilepsy, fileno, fund, Global, identified, intellectual, INVEGATM, irritability, Jr, main, mania, McCoy, monotherapy, onForm, paliperdone, Perez, portfolio, prophylactic, proton, pump, rating, received, Scientist, seek, Senior, Sherilyn, smaller, Strategy, target, thisForm
Filing tables
Filing exhibits
- 10-K Annual report
- 10 EX-10.R: Summary of Compensation Arrangements for Named Executive Officers and Directors
- 12 EX-12: Statement of Computation of Ratio of Earnings to Fixed Charges
- 13 EX-13: Pages 36 Through 77 of the Company's Annual Report to Shareholders
- 21 EX-21: Subsidiaries
- 23 EX-23: Consent of Pricewaterhousecoopers LLP
- 31 EX-31.A: Certification
- 31 EX-31.B: Certification
- 32 EX-32.A: Certification
- 32 EX-32.B: Certification
- 99 EX-99: Cautionary Statement
Related press release
JNJ similar filings
Filing view
External links